Abstract
We have produced a cell line which lacks the protein tyrosine kinase JAK1 and is completely defective in interferon response. Complementation of this mutant with JAK1 restored the response, establishing the requirement for JAK1 in both the interferon-α/β and -γ signal transduction pathways. The reciprocal interdependence between JAK1 and Tyk2 activities in the interferon-α pathway, and between JAK1 and JAK2 in the interferon-γ pathway, may reflect a requirement for these kinases in the correct assembly of interferon receptor complexes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
De Maeyer, E. & De Maeyer-Guignard, J. Interferons and Other Regulatory Cytokines (Wiley, New York, 1988).
Pestka, S., Langer, T. A., Zoon, K. C. & Samuel, C. E. Rev. Biochem. 56, 727–777 (1987).
Pellegrini, S. & Schindler, C. Trends Biochem. Sci. 18, 338–342 (1993).
Fu, X.-F., Schindler, C., Improta, T., Aebersold, R. & Darnell, J. E. Jr Proc. natn. Acad. Sci. U.S.A. 89, 7840–7843 (1992).
Gutch, M. J., Daly, C. & Reich, N. Proc. natn. Acad. Sci. U.S.A. 89, 11411–11415 (1992).
Schindler, C., Fu, X.-Y., Improta, T., Aebersold, R. & Darnell, J. E. Jr Proc. natn. Acad. Sci. U.S.A. 89, 7836–7839 (1992).
Schindler, C., Shuai, K., Prezioso, V. R. & Darnell, J. E. Jr Science 257, 809–813 (1992).
Veals, S. A. et al. Molec. cell. Biol. 12, 3315–3324 (1992).
Veals, S. A., Santa Maria, T. & Levy, D. E. Molec. cell. Biol. 13, 196–206 (1993).
Dale, T. C., Imam, A. M. A., Kerr, I. M. & Stark, G. R. Proc. natn. Acad. Sci. U.S.A. 86, 1203–1207 (1989).
Kessler, D. S., Veals, S. A., Fu, X.-Y. & Levy, D. E. Genes Dev. 4, 1753–1755 (1990).
Levy, D. E., Kessler, D. S., Pine, R. & Darnell, J. E. Jr Genes Dev. 3, 1362–1371 (1989).
Shuai, K., Schindler, C., Prezioso, V. R. & Darnell, J. E. Jr Science 258, 1808–1812 (1992).
Müller, M. et al. EMBO J. 12, 4221–4228 (1993).
Decker, T., Lew, D. J., Mirkovitch, J. & Darnell, J. E. Jr EMB0 J. 10, 927–932 (1991).
Lew, D. J., Decker, T., Strehlow, I. & Darnell, J. E. Jr Molec. cell. Biol. 11, 182–191 (1991).
Kanno, Y. et al. Molec. cell. Biol. 13, 3951–3963 (1993).
Khan, K. D. et al. Proc. natn. Acad. Sci. U.S.A. 90, 6806–6810 (1993).
Pearse, R. N., Feinman, R., Shuai, K., Darnell, J. E. Jr & Ravetch, J. V. Proc. natn. Acad. Sci. U.S.A. 90, 4314–4318 (1993).
Perez, C., Wietzerbin, J. & Benech, P. D. Molec. cell. Biol. 13, 2182–2192 (1993).
Aguet, M., Dembic, Z. & Merlin, G. Cell 55, 273–280 (1988).
Uzé, G., Lutfalla, G. & Gresser, I. Cell 60, 225–235 (1990).
Platanias, L. C. & Colamonici, O. R. J. biol. Chem. 267, 24053–24057 (1992).
Cook, J. R., Jung, V., Schwartz, B., Wang, P. & Pestka. S. Proc. natn. Acad. Sci. U.S.A. 89, 11317–11321 (1992).
Farrar, M. A., Campbell, J. D. & Schreiber, R. D. Proc. natn. Acad. Sci. U.S.A. 89, 11706–11710 (1992).
Wilks, A. F. Proc. natn. Acad. Sci. U.S.A. 86, 1603–1607 (1989).
Wilks, A. F. et al. Molec. cell. Biol. 11, 2057–2065 (1991).
Harpur, A. G., Andrew, A.-C., Ziemiecki, A., Aston, R. R. & Wilks, A. F. Oncogene 7, 1347–1353 (1992).
Howard, O. M. Z. et al. Oncogene 7, 895–900 (1992).
Silvennoinen, O. et al. Proc. natn. Acad. Sci. U.S.A. 90, 8429–8433 (1993).
Firmbach-Kraft, I., Byers, M., Shows, T., Dalla-Favera, R. & Krolewski, J. J. Oncogene, 5, 1329–1336 (1990).
Velazquez, L., Fellous, M., Stark, G. R. & Pellegrini, S. Cell 70, 313–322 (1992).
Pellegrini, S., John, J., Shearer, M., Kerr, I. M. & Stark, G. R. Molec. cell Biol. 9, 4605–4612 (1989).
McKendry, R. et al. Proc. natn. Acad. Sci. U.S.A. 88, 11455–11459 (1991).
Pine, R., Decker, T., Kessler, D. S., Levy, D. E. & Darnell, J. E. Jr Molec. cell. Biol. 10, 2448–2457 (1990).
Sims, S. H. et al. Molec. cell. Biol. 13, 690–702 (1993).
Bolen, J. B. Oncogene 8, 2025–2031 (1993).
Argetsinger, L. S. et al. Cell 74, 237–244 (1993).
Witthuhn, B. A. et al. Cell 74, 227–236 (1993).
Beyers, A. D., Spruyt, L. L. & Williams, A. F. Trends Cell Biol. 2, 253–255 (1992).
Weiss, A. Cell 73, 209–212 (1993).
David, M., Romero, G., Zhang, Z.-Y., Dixon, J. E. & Larner, A. C. J. biol. Chem. 268, 6593–6599 (1993).
Levy, D. E. & Darnell, J. E. Jr New Biol. 2, 923–928 (1990).
Stahl, N. & Yancopoulos, G. D. Cell 74, 587–590 (1993).
Larner, A. C. et al. Science 261, 1730–1733 (1993).
Ruff-Jamison, S., Chen, K. & Cohen, S. Science 261, 1733–1736 (1993).
Silvennoinen, O., Schindler, C., Schlessinger, J. & Levy, D. E. Science 261, 1736–1739 (1993).
Sadowski, H. B., Shuai, K., Darnell, J. E. Jr & Gilman, M. Z. Science 261, 1739–1744 (1993).
Seed, B. Nature 329, 840–842 (1987).
Claesson, L., Larhammar, D., Rask, L. & Peterson, P. A. Proc. natn. Acad. Sci. U.SA. 80, 7395–7399 (1983).
Watling, D. et al. Nature 366, 166–170 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Müller, M., Briscoe, J., Laxton, C. et al. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature 366, 129–135 (1993). https://doi.org/10.1038/366129a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/366129a0
This article is cited by
-
Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship
Molecular Diversity (2024)
-
Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1
Journal of Experimental & Clinical Cancer Research (2023)
-
JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences
Journal of Clinical Immunology (2023)
-
The JAK/STAT signaling pathway: from bench to clinic
Signal Transduction and Targeted Therapy (2021)
-
Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy
Journal of Clinical Immunology (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.